NASDAQ: ALZN - Alzamend Neuro, Inc.

六个月盈利: -37.28%
股息率: 0.00%
部门: Healthcare

促销时间表 Alzamend Neuro, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Alzamend Neuro, Inc.

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.

更多详情
The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2021-06-15
ISIN US02262M3088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.alzamend.com
Цена ао 1
每日价格变化: -3.64% (1.1)
每周价格变化: +4.95% (1.01)
每月价格变化: +22.54% (0.865)
3个月内价格变化: -11.67% (1.2)
六个月内的价格变化: -37.28% (1.69)
每年价格变化: +6% (1)
3年内价格变化: -14.52% (1.24)
年初以来价格变化: -11.67% (1.2)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV -1.85 0
P/E 0 0
EV/EBITDA -0.4789 0
全部的: 2.5

效率

姓名 意义 年级
ROA, % -303.88 0
ROE, % -4408.31 0
全部的: 1.67

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0304 10
全部的: 8.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 124.7 10
盈利能力 EPS, % 29906.76 10
全部的: 8
更多详情

机构 体积 分享, %
Truist Financial Corp 154327 2.25
Vanguard Group Inc 78545 1.14
Geode Capital Management, LLC 52397 0.76
Blackrock Inc. 39740 0.58
HRT Financial LP 16806 0.24
RFG Advisory, LLC 16666 0.24
Renaissance Technologies, LLC 10190 0.15
Tower Research Capital LLC (TRC) 3316 0.05
UBS Group AG 1909 0.03
HARBOR INVESTMENT ADVISORY, LLC 200 0



导师 职称 支付 出生年份
Mr. Stephan Jackman CEO & Director 434.24k 1976 (49 年)
Mr. David J. Katzoff Chief Financial Officer 116.67k 1962 (63 年)
Mr. Henry C. W. Nisser Esq. Executive VP, General Counsel & Director 50k 1969 (56 年)
Mr. Milton Charles Ault III Founder & Vice Chairman N/A 1970 (55 年)

地址: United States, Atlanta. GA, 3480 Peachtree Road NE - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.alzamend.com